Sphingosine-1 Phosphate Prevents Monocyte / Endothelial Interactions in Type 1 Diabetic NOD Mice Through Activation of the S 1 P 1 Receptor

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 12/15 Lipoxygenase Mediates Monocyte Adhesion to Aortic Endothelium in Apolipoprotein E–Deficient Mice Through Activation of RhoA and NF-&kgr;B

  2006cited by this paper
• S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.

  2005cited by this paper
• Sphingosine-1-Phosphate Prevents Tumor Necrosis Factor-&agr;–Mediated Monocyte Adhesion to Aortic Endothelium in Mice

  2005cited by this paper
• Sphingosine 1-Phosphate Analogs as Receptor Antagonists*

  2005cited by this paper
• Cutting Edge: Regulation of T Cell Trafficking and Primary Immune Responses by Sphingosine 1-Phosphate Receptor 1

  2005cited by this paper
• Sphingosine 1‐phosphate and its type 1 G protein‐coupled receptor: trophic support and functional regulation of T Lymphocytes

  2004cited by this paper
• Diabetes and atherogenesis

  2004cited by this paper
• Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

  2004cited by this paper
• Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate*

  2004cited by this paper
• Modulation of PPARα Expression and Inflammatory Interleukin-6 Production by Chronic Glucose Increases Monocyte/Endothelial Adhesion

  2004cited by this paper
• Sphingosine 1-Phosphate ( S 1 P ) Receptor Subtypes S 1 P 1 and S 1 P 3 , Respectively , Regulate Lymphocyte Recirculation and Heart Rate *

  2004cited by this paper
• The Sphingosine-1-phosphate Receptors S1P1, S1P2, and S1P3 Function Coordinately during Embryonic Angiogenesis*

  2004cited by this paper
• High-Density Lipoprotein Stimulates Endothelial Cell Migration and Survival Through Sphingosine 1-Phosphate and Its Receptors

  2003cited by this paper
• Increased Production of 12/15 Lipoxygenase Eicosanoids Accelerates Monocyte/Endothelial Interactions in Diabetic db/db Mice*

  2003cited by this paper
• Glucose Regulates Monocyte Adhesion Through Endothelial Production of Interleukin-8

  2003cited by this paper
• Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist.

  2002cited by this paper
• Sphingosine kinases: a novel family of lipid kinases.

  2002cited by this paper
• Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

  2002cited by this paper
• Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption.

  2001cited by this paper
• Sphingosine 1-Phosphate May Be a Major Component of Plasma Lipoproteins Responsible for the Cytoprotective Actions in Human Umbilical Vein Endothelial Cells*

  2001cited by this paper
• Sphingosine 1-Phosphate Activates Akt, Nitric Oxide Production, and Chemotaxis through a GiProtein/Phosphoinositide 3-Kinase Pathway in Endothelial Cells*

  2001cited by this paper
• Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

  2000cited by this paper
• Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

  2000cited by this paper
• Type 2 diabetes and atherosclerosis

  2000cited by this paper
• Sphingosine‐1‐Phosphate Signaling via the EDG‐1 Family of G‐Protein‐Coupled Receptors

  2000cited by this paper
• Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Complications

  2000cited by this paper
• Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction.

  1999cited by this paper
• Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells.

  1999cited by this paper
• Differential Coupling of the Sphingosine 1-Phosphate Receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq, and G12 Families of Heterotrimeric G Proteins*

  1999cited by this paper
• Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice.

  1999cited by this paper
• Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway.

  1998cited by this paper
• Interaction of diabetes and hypertension on determinants of endothelial adhesiveness.

  1998cited by this paper
• L-selectin-dependent leukocyte adhesion to microvascular but not to macrovascular endothelial cells of the human coronary system.

  1997cited by this paper
• Novel Vascular Molecule Involved in Monocyte Adhesion to Aortic Endothelium in Models of Atherogenesis

  1997cited by this paper
• Anti-CD43 inhibits monocyte-endothelial adhesion in inflammation and atherogenesis.

  1997cited by this paper
• Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.

  1997cited by this paper
• The Inducible G Protein-coupled Receptor edg-1 Signals via the G/Mitogen-activated Protein Kinase Pathway (*)

  1996cited by this paper
• Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.

  1994cited by this paper
• Regulation of monocyte and neutrophil entry into the vessel wall.

  1993cited by this paper
• The non-obese diabetic (NOD) mouse.

  1987cited by this paper
• The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions.

  1981cited by this paper

• Saliva metabolomic profile of COVID-19 patients associates with disease severity

  2022cites this paper
• The role of sphingolipid signalling in diabetes-associated pathologies (Review)

  2017cites this paper
• A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex

  2017cites this paper
• Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation

  2015cites this paper
• HDL and endothelial protection

  2013cites this paper
• Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells

  2013cites this paper
• Circulating sphingolipid biomarkers in models of type 1 diabetes

  2011cites this paper
• Endothelial Functions of Sphingosine-1-phosphate

  2010cites this paper
• Pharmacological pre‐ and post‐conditioning with the sphingosine‐1‐phosphate receptor modulator FTY720 after myocardial ischaemia–reperfusion

  2010cites this paper
• Lysophospholipids: two-faced mediators in atherosclerosis

  2007cites this paper
• Response to Letter Regarding Article , “ High-Density Lipoproteins and Their Constituent , Sphingosine-1-Phosphate , Directly Protect the Heart Against Ischemia / Reperfusion Injury In Vivo via the S 1 P 3 Lysophospholipid Receptor

  2006cites this paper